BK

Birendra Kumar Singh

Active Director Managing Director DIN 06780404
DIN 06780404 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Jan 2014
Shareholding value •••• Premium profile

About Birendra Kumar Singh

Data last updated:

Birendra Kumar Singh is a Managing Director at Li Shanto Pharmaceuticals Private Limited (since 2020), Director at Indimpex Megatrade Private Limited (since 2014) and Director at Aeybee Lifesciences Private Limited (since 2022). The companies operate in Pharma, Trading and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.62 Cr; the largest is Li Shanto Pharmaceuticals Private Limited at ₹1.53 Cr (FY 2024).

DIN 06780404
Primary Designation Managing Director
Industry Pharma
First Appointment 31 Jan 2014
Oldest Company Age 12 yrs
Largest company Li Shanto Pharmaceuticals Private Limited · ₹1.53 Cr (FY 2024)
Combined revenue ₹1.62 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director24 Aug 20202020₹1.53 Cr (FY 2024)Active
Indimpex Megatrade Private Limited U51909JH2014PTC001945
Director31 Jan 20142014₹8.5 Lakh (FY 2025)Active
Aeybee Lifesciences Private Limited U33119DL2022PTC391992
Director04 Jan 20222022Active

Directorship timeline

Open interactive timeline →
Li Shanto Pharmaceuticals Private Limited
Aeybee Lifesciences Private Limited
Indimpex Megatrade Private Limited
Premium access

Shareholding and investment profile for Birendra Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Birendra Kumar Singh

Birendra Kumar Singh currently holds 3 directorships: Li Shanto Pharmaceuticals Private Limited (Managing Director, since 24 Aug 2020, revenue ₹1.53 Cr (FY 2024)); Indimpex Megatrade Private Limited (Director, since 31 Jan 2014, revenue ₹8.5 Lakh (FY 2025)); Aeybee Lifesciences Private Limited (Director, since 04 Jan 2022).

Birendra Kumar Singh was first appointed on 31 Jan 2014 as Director at Indimpex Megatrade Private Limited. The most recent appointment on record is 04 Jan 2022 at Aeybee Lifesciences Private Limited.

The 2 current companies of Birendra Kumar Singh that report revenue have a combined latest revenue of ₹1.62 Cr: Li Shanto Pharmaceuticals Private Limited ₹1.53 Cr (FY 2024); Indimpex Megatrade Private Limited ₹8.5 Lakh (FY 2025).

The current boards of Birendra Kumar Singh's companies include Akash Kumar (Li Shanto Pharmaceuticals Private Limited), Sanjeev Kumar (Li Shanto Pharmaceuticals Private Limited), Vikash Kumar Singh (Li Shanto Pharmaceuticals Private Limited), Devendra Singh (Indimpex Megatrade Private Limited), Raja Ranjan (Aeybee Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available